Literature DB >> 2995841

Cyclic AMP facilitates the electrically evoked release of radiolabelled noradrenaline, dopamine and 5-hydroxytryptamine from rat brain slices.

A N Schoffelmeer, G Wardeh, A H Mulder.   

Abstract

The adenylate cyclase activator forskolin as well as 8-bromo-cyclic AMP enhanced the electrically evoked release of 3H-noradrenaline and 3H-5-hydroxytryptamine from superfused rat neocortical slices and that of 3H-dopamine from neostriatal slices with comparable EC50's of about 0.5 and 50 microM, respectively, without affecting spontaneous tritium efflux. The phosphodiesterase inhibitor ZK 62771 (3-100 microM) also enhanced 3H-noradrenaline and 3H-dopamine release but slightly reduced 3H-5-hydroxytryptamine release. However, this drug profoundly enhanced spontaneous tritium release in the latter case. The facilitatory effect of forskolin (0.3 microM) on the release of the amine neurotransmitters was potentiated in the presence of ZK 62771 (30 microM). Therefore, cyclic AMP appears to exert a general facilitatory effect on the release of these biogenic amines from central nerve terminals.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2995841     DOI: 10.1007/bf00586712

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  16 in total

1.  Dopamine synthesis in rat brain striatal synaptosomes. II. Dibutyryl cyclic adenosine 3':5'-monophosphoric acid and 6-methyltetrahydropterine-induced synthesis increases without an increase in endogenous dopamine release.

Authors:  R L Patrick; J D Barchas
Journal:  J Pharmacol Exp Ther       Date:  1976-04       Impact factor: 4.030

2.  Possible role of cyclic nucleotides in regulation of noradrenaline release from rat pineal through presynaptic adrenoceptors.

Authors:  F Pelayo; M L Dubocovich; S Z Langer
Journal:  Nature       Date:  1978-07-06       Impact factor: 49.962

3.  Accumulation of adenosine 3',5'-monophosphate in brain slices: interaction of local anaesthetics and depolarizing agents.

Authors:  H Shimizu; M Takenoshita; M Huang; J W Daly
Journal:  J Neurochem       Date:  1973-01       Impact factor: 5.372

Review 4.  An overview of subcellular localization, release and termination of action of amine, amino acid and peptide neurotransmitters in the central nervous system.

Authors:  A H Mulder
Journal:  Prog Brain Res       Date:  1982       Impact factor: 2.453

Review 5.  Protein phosphorylation in the brain.

Authors:  E J Nestler; P Greengard
Journal:  Nature       Date:  1983 Oct 13-19       Impact factor: 49.962

6.  Striatal dopamine release in vitro: a beta-adrenoceptor-regulated response not mediated through cyclic AMP.

Authors:  T Reisine; M F Chesselet; J Glowinski
Journal:  J Neurochem       Date:  1982-10       Impact factor: 5.372

7.  Evidence for a presynaptic adenylate cyclase system facilitating [3H]norepinephrine release from rat brain neocortex slices and synaptosomes.

Authors:  A N Schoffelmeer; F Hogenboom; A H Mulder
Journal:  J Neurosci       Date:  1985-10       Impact factor: 6.167

8.  Characterization of brain synaptic vesicle phospholipase A2 activity and its modulation by calmodulin, prostaglandin E2, prostaglandin F2 alpha, cyclic AMP, and ATP.

Authors:  N Moskowitz; S Puszkin; W Schook
Journal:  J Neurochem       Date:  1983-12       Impact factor: 5.372

9.  3H-noradrenaline release from rat neocortical slices in the absence of extracellular Ca2+ and its presynaptic alpha 2-adrenergic modulation. A study on the possible role of cyclic AMP.

Authors:  A N Schoffelmeer; A H Mulder
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-07       Impact factor: 3.000

10.  Forskolin and the release of noradrenaline in cerebrocortical slices.

Authors:  R Markstein; K Digges; N R Marshall; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-01       Impact factor: 3.000

View more
  16 in total

1.  Facilitation of serotonin (5-HT) release in the rat brain cortex by cAMP and probable inhibition of adenylate cyclase in 5-HT nerve terminals by presynaptic alpha 2-adrenoceptors.

Authors:  E Schlicker; K Fink; K Classen; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-09       Impact factor: 3.000

Review 2.  Pharmacology of nootropics and metabolically active compounds in relation to their use in dementia.

Authors:  C D Nicholson
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

3.  Effects of the phosphodiesterase inhibitor rolipram on the acoustic startle response in rats.

Authors:  J H Kehne; N M Boulis; M Davis
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

4.  Inhibition of type 4 cAMP-phosphodiesterases (PDE4s) in mice induces hypothermia via effects on behavioral and central autonomous thermoregulation.

Authors:  Will McDonough; Justin Rich; Ileana V Aragon; Lina Abou Saleh; Abigail Boyd; Aris Richter; Anna Koloteva; Wito Richter
Journal:  Biochem Pharmacol       Date:  2020-07-20       Impact factor: 5.858

5.  Involvement of adenylate cyclase and protein kinase C in the alpha 2-adrenoceptor-mediated inhibition of noradrenaline and 5-hydroxytryptamine release in rat hypothalamic slices.

Authors:  R Ramdine; A M Galzin; S Z Langer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-10       Impact factor: 3.000

6.  Involvement of cyclic AMP systems in morphine physical dependence in mice: prevention of development of morphine dependence by rolipram, a phosphodiesterase 4 inhibitor.

Authors:  T Mamiya; Y Noda; X Ren; M Hamdy; S Furukawa; T Kameyama; K Yamada; T Nabeshima
Journal:  Br J Pharmacol       Date:  2001-03       Impact factor: 8.739

7.  The PDE4 inhibitor rolipram reverses object memory impairment induced by acute tryptophan depletion in the rat.

Authors:  K Rutten; C Lieben; L Smits; A Blokland
Journal:  Psychopharmacology (Berl)       Date:  2007-01-30       Impact factor: 4.530

8.  Distinct roles of PDE4 and PDE10A in the regulation of cAMP/PKA signaling in the striatum.

Authors:  Akinori Nishi; Mahomi Kuroiwa; Diane B Miller; James P O'Callaghan; Helen S Bateup; Takahide Shuto; Naoki Sotogaku; Takaichi Fukuda; Nathaniel Heintz; Paul Greengard; Gretchen L Snyder
Journal:  J Neurosci       Date:  2008-10-15       Impact factor: 6.167

9.  The 5-hydroxytryptamine 5-HT1D receptor subtype is negatively coupled to adenylate cyclase in calf substantia nigra.

Authors:  P Schoeffter; C Waeber; J M Palacios; D Hoyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-06       Impact factor: 3.000

Review 10.  Selective phosphodiesterase inhibitors: a promising target for cognition enhancement.

Authors:  Olga A H Reneerkens; Kris Rutten; Harry W M Steinbusch; Arjan Blokland; Jos Prickaerts
Journal:  Psychopharmacology (Berl)       Date:  2008-08-16       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.